Fortune Soya Health Oil and the Wellness Positioning Strategy of Adani Wilmar

Executive Summary

Fortune, owned by Adani Wilmar Limited (renamed AWL Agri Business Limited in February 2025 following shareholder approval), is India's largest-selling edible oil brand. Over roughly a decade, the brand pursued "health" as a core positioning lever inside a structurally commoditised category — moving from an aggressive, disease-linked health claim (Fortune Vivo, "India's first diabetes care oil," 2016) that triggered regulatory action, to a more cautious, FSSAI-compliant nutritional-balance campaign for Fortune Xpert Total Balance Oil ("Health Aaj Se," 2023), alongside its long-running flagship Fortune Soya Health Oil and complementary CSR-linked nutrition programs. This case traces that evolution using only publicly documented facts, examines the commercial logic and regulatory consequences of each phase, and draws out lessons on the boundary between nutritional claims and health/therapeutic claims in regulated FMCG categories.

Industry and Competitive Context

India's branded edible oil industry is characterised by low consumer involvement, high price elasticity, and limited intrinsic product differentiation, since oil is a near-commodity input rather than a brand-driven purchase in most households. Growth in the organised segment has historically come from converting unbranded, loose-oil consumption into packaged, branded formats sold through a wide retail network. As of 2021, Adani Wilmar held an 18.3% share of India's branded edible oil market, the largest share in the domestic industry, as disclosed in the company's public filings around its IPO. The company was the market leader in soyabean oil, mustard oil, and rice bran oil, and ranked among the top three players in palm oil and sunflower oil; it has also been described as India's largest processor of edible oils and largest processor of palm oil. The company's distribution network comprised more than 10,000 distributors and close to 2.1 million retail outlets, according to publicly available company documentation, and Wilmar International's published annual materials stated that one in three Indian households used an AWL product as of December 2022. Within the "health oil" sub-segment specifically, Marico's Saffola has historically held the pioneering position in India through its long-running "heart health" positioning, predating Fortune's health-oriented campaigns. Emami Agrotech's "Healthy and Tasty" range has also competed in this space. Fortune's health-oil strategy therefore had to contend with an established category leader on the "heart health" claim, which shaped its choice to differentiate on disease-specific therapeutic positioning (Vivo) and later on a multi-oil nutritional-balance claim (Xpert Total Balance), rather than competing directly on Saffola's heart-health territory. The company went public via a three-day IPO that opened on 27 January 2022 and closed on 31 January 2022, with listing on 8 February 2022. In December 2024, Adani Enterprises announced its exit from the Adani Wilmar joint venture, selling its 44% stake to public shareholders and to Wilmar International; this exit was completed in November 2025, after which the company operated solely as AWL Agri Business Limited.

Brand Situation Prior to the Campaign

Fortune entered the "functional health oil" space in February 2016 with Fortune Vivo, which the company publicly described, through its then-CEO Atul Chaturvedi, as India's first "diabetes care oil," intended to help control Type II diabetes. The product was deliberately positioned as a premium, niche offering — targeted, in the company's own words at launch, at "the upper segment with a higher income bracket who are likely to get lifestyle diseases" — rather than as a mass-market oil, and was rolled out initially in 18 cities with national availability planned by the end of March of that year. This launch represented a category-creation attempt: rather than entering the established "heart health" territory already owned by Saffola, Adani Wilmar sought to define a new, more specific health sub-claim tied to a named disease condition. This was a higher-risk strategic choice, since therapeutic or disease-management claims attract a materially stricter regulatory standard in India than general nutritional claims. The risk materialised. The Advertising Standards Council of India (ASCI) investigated Fortune Vivo's marketing claims and found them misleading. When Adani Wilmar contested this finding, the Ahmedabad City Civil Court ruled in January 2017 in favour of ASCI, holding, as reported by The Ken, that the "Fortune Vivo diabetes care oil" health claim was "misleading with ambiguity" and that it would affect public health. Separately, in 2016, the Government of Maharashtra's Food and Drug Administration stated that Adani Wilmar had violated FDA regulations in promoting Fortune Vivo, citing claims about the oil's medicinal properties, including its purported ability to regulate diabetes; Madan Yerawar, the Minister of State for FDA, stated that a raid had been conducted on the company's storage facility in Panvel after deceptive information was identified on both product advertisements and packaging. These are the only specific regulatory actions against a Fortune health-oil claim that are documented in publicly available sources.

Strategic Objective

Following the Vivo episode, the publicly observable trajectory of Fortune's communication shifted toward nutritional claims that are explicitly anchored to standards published by the Food Safety and Standards Authority of India (FSSAI), rather than to disease-specific therapeutic outcomes. The clearest documented expression of this recalibrated strategy is the 2023 launch campaign for Fortune Xpert Total Balance Oil, titled "Health Aaj Se" ("Health From Today"), conceived by Ogilvy and described by the company as a 360-degree, multi-platform campaign. The stated objective of this campaign, as communicated by Adani Wilmar through its official channels, was twofold: first, to introduce Fortune Xpert Total Balance Oil — a tri-oil blend of soyabean, rice bran, and flaxseed oils — as a single product offering a holistic nutritional solution; and second, to address a behavioural insight about Indian consumers' tendency to perpetually defer health commitments. Vineeth Viswambharan, Associate Vice President, Marketing & Sales at Adani Wilmar, stated in the campaign's official launch communication that the company placed "great importance on nutritional value that consumers seek in their grocery choices," and characterised the new product launch as "a game-changer in the edible oil segment, as Indians have become extremely health-conscious in the post-pandemic world."

Campaign Architecture and Execution

The "Health Aaj Se" campaign was built around a specific, publicly documented consumer insight: the tendency of Indian consumers to postpone health commitments with phrases such as "Gym – Kal Se" (gym from tomorrow), "Yoga – Kal Se," and "Diet – Kal Se" — a colloquial pattern of habitual deferral. The campaign's narrative answer was that a health journey could begin immediately, in the kitchen, through the cooking oil used that day, rather than through a future resolution. Execution took the form of a series of three short television commercials, each centred on individuals planning a fitness journey who are ultimately persuaded by loved ones that health should not be delayed and can begin "Aaj Se" (from today) with Fortune Xpert Total Balance Oil. The campaign was distributed across digital platforms, offline modern trade outlets, HD channels, connected TVs, and what the company described as "other alternative media," in pursuit of broad reach across both traditional and digital touchpoints. The product itself was made available in a 1-litre pouch and a 5-litre jar format, alongside two related Xpert sub-variants — Fortune Xpert Pro Sugar Conscious and Fortune Xpert Pro Immunity — sold through e-commerce as well as conventional retail. Architecturally, the critical distinction from the earlier Vivo campaign is that all health-related claims in "Health Aaj Se" were grounded in FSSAI-defined nutritional parameters — specifically the SAFA:PUFA:MUFA (saturated, polyunsaturated, and monounsaturated fatty acid) ratio and the Omega-3:Omega-6 ratio recommended for a balanced diet based on average Indian dietary patterns — rather than in a named disease-management claim. The brand's advertising materials described the resulting blend as supporting a "low-cholesterol" diet profile and offering "anti-inflammatory characteristics," framed as nutritional rather than therapeutic attributes. Beyond the Xpert launch, Fortune's flagship Fortune Soya Health Oil and Fortune Kachi Ghani Mustard were also featured in a separate brand campaign, "Ghar Ka Khana Ghar Ka Khana Hota Hai" ("Home Food Is Home Food"), crafted by Ogilvy India and directed by Piyush Pandey. This campaign was emotionally rather than nutritionally led: set in a restaurant, it followed a diner whose memory of a home-cooked dish ("bharwa baingan," or stuffed brinjal) transports him back to his mother's kitchen, with the cooking process shown using Fortune Soya Health Oil. The campaign's stated objective, per Mukesh Mishra, Vice President–Sales & Marketing at Adani Wilmar, was to "encourage individuals to rediscover the joy of making and eating handmade meals, thereby strengthening ties with their loved ones" — a positioning built on nostalgia and domestic wellbeing rather than on a specific nutritional claim. In a related, publicly documented activation, Adani Wilmar partnered with the Mumbai Dabbawala Association around World Protein Day to distribute packs of Fortune Soya Chunks through the dabbawalas' lunchbox delivery network. Each dabbawala was provided with Fortune Soya-branded t-shirts and informational leaflets attached to tiffin boxes, explaining the benefits of protein-rich foods, and the dabbawalas themselves received product packs as part of the activation. This initiative is documented as reinforcing the broader "Ghar Ka Khana" brand message through an experiential, on-ground distribution channel rather than mass media. On the corporate social responsibility side, Adani Wilmar, together with the Adani Foundation, runs the Fortune SuPoshan initiative, a publicly documented program aimed at addressing malnutrition and anaemia among children. This initiative situates the Fortune brand's "wellness" association at a social and nutritional-policy level, complementing the product-level health claims made in commercial advertising.

Positioning and Consumer Insight

Across the documented campaigns, Fortune's positioning logic shows a consistent attempt to occupy "health" territory that is adjacent to, but distinct from, Saffola's established heart-health claim — first through a disease-specific claim (Vivo, diabetes care), then through a multi-nutrient, FSSAI-referenced balance claim (Xpert Total Balance), and in parallel through an emotional, home-and-family-centred wellbeing claim (Soya Health Oil's "Ghar Ka Khana" narrative) that sidesteps clinical claims altogether in favour of associative, lifestyle-based wellness. The "Kal Se" consumer insight used in "Health Aaj Se" is notable as a behavioural rather than purely nutritional insight: it targets the well-documented psychological pattern of procrastination around health resolutions, and converts a routine, low-involvement purchase decision (which cooking oil to buy) into an entry point for a larger, aspirational health identity ("starting today"). This is a category-relevant adaptation of a broader habit-formation marketing logic, applied to a product where genuine functional differentiation is narrow and regulatorily constrained.

Media and Channel Strategy

Publicly available information confirms that the "Health Aaj Se" campaign used a multi-channel mix described by the company as "360-degree," spanning digital platforms, offline modern trade outlets, HD television channels, connected TV (CTV), and other alternative media, executed in partnership with Ogilvy. No verified public information is available on the specific media spend, channel-wise budget allocation, or audience-reach figures for this campaign. Similarly, no verified public information is available on the specific digital, influencer, or programmatic media partners used beyond the general channel categories disclosed by the company.

Business and Brand Outcomes

Fortune has been recognised with the "Most Trusted Brand" award by Reader's Digest for six consecutive years, as documented in official Adani Wilmar materials; it has also received the Frost & Sullivan India F&B Innovative Product of the Year award and a Superbrands recognition, per company and distributor-published brand materials. Fortune Xpert Total Balance Oil specifically received the "Product Launch of the Year" award at the Channelier FMCG Awards 2022, as listed in official company award records. On regulatory outcomes, the documented record shows a clear adverse finding against the earlier Vivo claim: the Ahmedabad City Civil Court ruled against the "diabetes care" claim in January 2017, following an adverse ASCI finding, and the Maharashtra FDA separately issued a violation notice and conducted a warehouse raid in 2016 over the same product's advertising and packaging claims. No equivalent adverse regulatory finding against the FSSAI-referenced "Health Aaj Se" / Xpert Total Balance campaign, or against the Soya Health Oil "Ghar Ka Khana" campaign, is documented in publicly available sources as of this case's compilation.

No verified public information is available on Fortune Soya Health Oil's or Fortune Xpert Total Balance Oil's category-specific sales volumes, market-share gains, revenue contribution, or campaign-attributed brand-recall or purchase-intent metrics. AWL Agri Business's investor disclosures report financial results at the consolidated and segment (edible oils, foods and FMCG, industry essentials) level rather than at the level of an individual SKU or campaign, and no source reviewed for this case isolates Fortune Soya Health Oil or the Xpert sub-brand within those disclosures.

Strategic Implications

The Fortune health-oil narrative illustrates a recurring tension in regulated, low-differentiation FMCG categories: the commercial incentive to claim a specific, defensible health benefit competes directly with the regulatory ceiling on what a food product (as distinct from a drug) is permitted to claim. Fortune Vivo's "diabetes care oil" positioning offered strong category-creation potential and premium pricing logic but crossed the line FSSAI and ASCI draw between a "nutritional claim" (e.g., "good source of Omega-3," "balanced fatty acid profile") and a "health claim" implying disease prevention or therapeutic benefit — a line that, per the documented court and FDA findings, the company did not successfully defend. The subsequent Xpert Total Balance / "Health Aaj Se" campaign reflects a more conservative claims architecture, anchoring its nutritional language explicitly to FSSAI-published ratios rather than to a named disease outcome, which is the more defensible regulatory posture for a packaged food product. The parallel "Ghar Ka Khana" campaign for the core Soya Health Oil line shows a third strategic path available to a brand operating under tight claims constraints: building "wellness" association through emotional and cultural meaning (home, family, nostalgia) rather than through any nutritional or clinical claim at all, which carries effectively no regulatory exposure. Taken together, the documented record across Fortune's campaigns suggests that, in a category where genuine functional differentiation is narrow and tightly regulated, sustainable "health" positioning is more durable when it is built on (a) FSSAI-anchored nutritional language that is precise and defensible, and/or (b) emotional and cultural associations with wellbeing that do not depend on a contestable health claim — rather than on aggressive, disease-specific positioning of the kind attempted with Fortune Vivo.

Discussion Questions

1. Compare Fortune Vivo's "diabetes care oil" positioning with Fortune Xpert Total Balance's FSSAI-anchored "balance" claim. What does the regulatory outcome of each suggest about the boundary between a "nutritional claim" and a "health claim" in food marketing, and how should brand managers in regulated categories test claims before launch?

   
   

2. Saffola is documented as having pioneered "heart health" positioning in the Indian edible oil category before Fortune's health-oil initiatives. What strategic options does a market-leading challenger brand (by overall share) have when a smaller competitor already owns the dominant health-positioning territory in a category?

   
   

3. The "Ghar Ka Khana Ghar Ka Khana Hota Hai" campaign builds a wellness association through emotional and cultural meaning rather than a nutritional claim. Evaluate the trade-offs between claim-based health positioning and emotion-based wellness positioning for a commodity FMCG product, in terms of differentiation, regulatory risk, and long-term brand equity.

   
   

4. Using only the publicly available facts in this case, what gaps exist in assessing whether Fortune's health-oil campaigns achieved their stated commercial objectives? What categories of data would a marketing analyst need from non-public sources to properly evaluate campaign ROI?

   
   

5. Adani Wilmar's CSR-linked Fortune SuPoshan initiative addresses child malnutrition and anaemia, operating alongside the brand's commercial health-oil campaigns. What is the strategic rationale for pairing a commercial wellness positioning with a social-impact nutrition program, and what risks or benefits does this dual approach carry for brand credibility?